Medicine and Health Sciences Commons^™

Assessment Of Portal System Hemodynamics For The Prediction Of Portal-Vein Thrombosis In Cirrhosis - A Systematic Review And Meta-Analysis, Marko Kozyk, Suprabhat Giri, Ankita Singh, Kailash Kolhe, Akash Roy, Kateryna Strubchevska

Conference Presentation Abstracts

Background: The pathogenesis of portal vein thrombosis (PVT) in cirrhosis is multifactorial, with altered hemodynamics being proposed as a possible contributor. The present systematic review was conducted to study the role of assessment of portal hemodynamics for the prediction of PVT in patients with cirrhosis. Methods: Three databases (Medline, Embase, and Scopus) were searched from inception to February 2023 for studies comparing portal venous system parameters in patients with cirrhosis developing PVT with those not. Results were presented as mean difference (MD) or odds ratio (OR) with their 95% confidence intervals (CI). Results: A total of 31 studies (patients with …

Rare Presentation Of Metastatic Hepatocellular Carcinoma In The Finger: Case Report And Review Of Literature, F. Rhana Mousavi, Bassem Bekheit, Emon Alavi, Nick A. Hirad, Abanoub Gabra

Research Day

Hepatocellular carcinoma (HCC) is a primary tumor of the liver that primarily develops in the setting of chronic liver disease. HCC is difficult to diagnose due to it requiring the use of multiple imaging modalities with the goal to detect tumors when they are less than or equal to 2 cm in size to allow all possible treatment options to be used. Herein, we discuss a 69-year-old male with stage IV liver cancer residing in hospice presenting with left middle finger osteomyelitis and extreme pain. Radiology revealed a destructive lesion but pathology provided the diagnosis of metastatic hepatocellular carcinoma in …

Serum Level Of Tnfα And Its Gene Polymorphism Association With Hepatocellular Carcinoma, Ahmed Ahmed Elshaarawy, Eman Ahmed Gawish, Noha Rabee Bayoumi, Asmaa Zaky Turky, Karema Abd Elhady Diab

Menoufia Medical Journal

Objectives: To evaluate serum level of TNFα and its gene polymorphism association with hepatocellular carcinoma

Background: HCC is one of the commonest fatal tumors worldwide, so it is a major international public health and considered the third leading cause of cancer death in the world.HCC is the second and sixth most prevalent cancer in men and women, respectively in Egypt. TNFα is a pleiotropic cytokine mainly produced by monocytes and macrophages. It has been linked to a number of physiological and pathological disorders. TNFα serum levels and its gene polymorphism have been shown to be significantly elevated in patients with …

Pharmacy Newsletter : April 2023, Pharmacy Department

Pharmacy Newsletter

• Changes in Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report
• TOX-TOK: Sulfonylurea Overdose
• Difference Between Parenteral Iron Products
• Drug-Drug Interactions Impacting the Treatment of HIV-TB Co-Infection
• Conversion Between Different Corticosteroid Preparations
• Use of Analgesics in Adult Patients with Cirrhosis

Failure To Treat Hcv In Patients Seen In A Predominately African American Socioeconomically Challenged Population, Crisshy Auguste, Paul H. Naylor Phd, Murray N. Ehrinpreis Md, Milton G. Mutchnik Md

Medical Student Research Symposium

The research objective of this proposal is to investigate the impediment with respect to moving a patient from initial antibody/PCR positive to successful completion of treatment. Secondary objectives include determining the most effective way for patients to progress from initial antibody/PCR positive to treatment and identifying the roadblocks for HCV antibody/PCR positive patients to be treated effectively.

Data was collected from 2019 HCV patient EMR charts, including demographics, laboratory studies, and treatment history. Concerning treatment, we evaluated linkage to the care; we defined success as treatment within six months of the initial visit. Thus, data on treatment initiation was collected …

Serum Beta-2 Microglobulin In Patients With Chronic Hepatitis C Virus With Or Without Hepatocellular Carcinoma, Amera F. Shehata, Ayman M. El-Lehleh, Moamena S. El-Hamoly, Randa M. Seddik, Walid A. Ghonim

Menoufia Medical Journal

Objectives To investigate serum beta-2 microglobulin (B2M) as a noninvasive marker for disease progression in chronic hepatitis C virus (HCV)-infected patients and to study its role as a tumor marker in diagnosis of hepatocellular carcinoma (HCC). Background HCV is a hepatotropic RNA virus that causes progressive liver damage, which might result in liver cirrhosis and HCC. Patients and methods From January 2020 to January 2022, this prospective study was carried on 136 participants who were classified into four groups: group I, 22 patients with noncirrhotic chronic hepatitis C; group II, 70 HCV-related cirrhotic patients; group III, 25 patients with HCC …